Fundraising FoxBlue Owl Capital — 2025 Investments
4 investments dated 2025 · listed companies and verified rows first · show all
Clio provides cloud-based legal practice management software and client communication tools for law firms to streamline operations and improve client service.
AI & Machine LearningCloud ComputingLegalTechSaaSVancouver, CA
Jack Newton(Founder)inRian Gauvreau(Founder)Sergey Konchakovskiy(Director, Chief Executive Officer)Ryan Wong(Founder)
BoardJulian Steinberg(Director)John Bush(Director)
Co-investorsActon CapitalBessemer Venture PartnersCapitalGIntrepid Growth PartnersJMI EquityNew Enterprise Associates (NEA)+8 more
Crusoe builds energy-first AI infrastructure, using innovative and renewable energy sources to power hyperscale AI factories and a cloud platform for AI workloads.
AI & Machine LearningCloud ComputingData & InfrastructureEnergyDenver, US
Cully Cavness(Founder)inChase Lochmiller(Founder)inCharles Cavness(Executive Officer, Director)Matthew DeNezza(Executive Officer)inJamey Seely(Executive Officer)inMichael Gordon(Executive Officer)in
Co-investorsAbstract VenturesACTIVATE CAPITAL PARTNERSAdvaita CapitalAir Street CapitalAkkaAlkeon Innovation+74 more
Juniper Square provides an investor management platform for private investment firms, combining an investor portal, investor CRM, and reporting tools to manage investments from onboarding through final sale.
AI & Machine LearningEnterprise SoftwareFintechPropTechSaaSSan Francisco, US
Alex Robinson(Founder)inAdam Ginsburg(Founder)inYonas Fisseha(Founder)inEric Jenny(Executive Officer)in
BoardNick Shalek(Director)inElliot Geidt(Director)in
Co-investorsFelicis VenturesFlex Capital PartnersHighsage VenturesOVO FundPrecursor VenturesRedpoint Ventures+5 more
Star Therapeutics develops treatments aimed at addressing real-world patient needs.
BiotechSouth San Francisco, US
Adam Rosenthal(Founder & CEO)inNancy Stagliano(Director)inMichelle Carpenter(Executive Officer)Sandip Panicker(Executive Officer)Scott Robertson(Executive Officer)inGary Patou(Executive Officer)in
Co-investorsFrazier Life SciencesOrbiMedRA CapitalSanofi VenturesSofinnova VenturesViking Global+11 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.